Altered coronary vascular responsiveness to leukotrienes in alloxan-diabetic rats.
- 1 April 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 54 (4) , 388-395
- https://doi.org/10.1161/01.res.54.4.388
Abstract
Altered responsiveness to and metabolism of various eicosanoids in diabetic animals and patients has been reported by several investigators. The purpose of this investigation was to examine the coronary vascular responsiveness of alloxan-diabetic rats to the leukotrienes. Hearts from 12- to 16-week-old alloxan-diabetic rats and weight-matched controls were perfused at constant flow by the Langendorff method. Coronary vasoactivity to leukotrienes B4, C4, D4 and E4 was assessed by measuring the change in coronary perfusion pressure upon infusion of these eicosanoids. Hearts from diabetic rats showed increased responsiveness to leukotrienes C4 (4-40 nM) and D4 (10-100 nM). Both control and diabetic rat hearts were only slightly responsive to leukotriene E4, and no difference between the two groups existed in the reactivity to this leukotriene. Neither group was responsive to the chemotactic leukotriene, B4. Perfusion of the hearts with the cyclooxygenase inhibitor, ibuprofen, failed to alter the coronary vascular responses to the leukotrienes. The coronary constrictor effects of the leukotrienes are the primary effect of these agents on the rat heart, since heart rate does not change significantly, and changes in contractile force are secondary to the coronary vascular constriction. These alterations in responsiveness to leukotrienes may play a role in the cardiovascular complications associated with diabetes.This publication has 24 references indexed in Scilit:
- Coronary vasoconstriction induced by leukotrienes in the anaesthetized dogEuropean Journal of Pharmacology, 1982
- Alloxan toxicity to the pancreatic B-cell: A new hypothesisBiochemical Pharmacology, 1982
- Leukotriene D 4 : a Potent Coronary Artery Vasoconstrictor Associated with Impaired Ventricular ContractionScience, 1982
- Coronary vasoconstriction and PGI2 release by leukotrienes in isolated guinea pig heartsEuropean Journal of Pharmacology, 1981
- Effects on prostaglandins F2α, I2, and indomethacin on isolated coronary arteries from healthy and alloxandiabetic dogsCellular and Molecular Life Sciences, 1981
- Streptozotocin: mechanisms of actionFEBS Letters, 1980
- Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound bay g 6575Thrombosis Research, 1980
- VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MANThe Lancet, 1979
- Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid ratsMetabolism, 1977
- On the Enzymatic Determination of Blood GlucoseScandinavian Journal of Clinical and Laboratory Investigation, 1960